Results 141 to 150 of about 246,859 (296)

Genetic Modifiers of Parkinson's Disease: A Case–Control Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To examine the associations of LRRK2 p.G2019S, GBA1 p.N409S, polygenic risk scores (PRS), and APOE E4 on PD penetrance, risk, and symptoms. Methods We conducted a US‐based observational case–control study using data from the 23andMe Inc. and Fox Insight Genetic Substudy (FIGS) databases.
Matthew J. Kmiecik, Michael V. Holmes, Pierre Fontanillas, Giulietta M. Riboldi, Ruth B. Schneider, Jingchunzi Shi, Anna Guan, Susana Tat, Steven Micheletti, Keaton Stagaman, Josh Gottesman, David A. Hinds, Joyce Y. Tung, 23andMe Research Team, Stella Aslibekyan, Lucy Norcliffe‐Kaufmann   +15 more
wiley   +1 more source

Is it time for a new measurement approach? A closer look at the assessment of cognitive adaptability in complex problem solving

Frontiers in Psychology, 2015
Ronny eScherer
doaj   +1 more source

Research on Educational Practice to Realize Constant Measuring Force in Measurement with External Micrometer

, 2013
Yasushi TAKEO, Wtaru NATSU
openalex   +2 more sources

Evaluating the cognitive output of the subject of educational measurement and evaluation for students of basic education faculties

, 2023
Yasser Mahmoud Wahib Al-Makdami, Muhammad Diaa Abdul Rasul, Bashar Ghaleb Shehab   +2 more
openalex   +1 more source

Analysis of Soluble Interleukin‐2 Receptor as a Prognostic Biomarker in NMOSD and MOGAD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Soluble interleukin‐2 receptor (sIL‐2R) is a biomarker for T cell activity. T cells are involved in neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte glycoprotein antibody‐associated disease (MOGAD) pathogenesis. However, sIL‐2R has so far not been evaluated in these conditions.
Philipp Klyscz, Carolin Otto, Klemens Ruprecht, Susanna Asseyer, Hannes Ole Tiedt, Christian Meisel, Judith Bellmann‐Strobl, Friedemann Paul, Patrick Schindler   +8 more
wiley   +1 more source

It is Time to Include Cost-Effectiveness in CME Outcomes Measurement. [PDF]

J CME
Dietze DT, Frimpter J.
europepmc   +1 more source

Evaluating Fairness of Automated Scoring in Educational Measurement

, 2023
Matthew Johnson, Daniel F. McCaffrey
openalex   +2 more sources

Plasma p‐tau181 as a Marker of Conversion to Alzheimer's Disease Dementia and Worsening in Cognitive Functions in Subjective Cognitive Decline and Mild Cognitive Impairment: A Longitudinal Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Plasma p‐tau181 has proven to be a promising diagnostic and prognostic tool in the earliest phases of Alzheimer's disease (AD). We aimed to evaluate the prognostic role of p‐tau181 in predicting conversion to AD dementia and worsening in cognition in mild cognitive impairment (MCI) and subjective cognitive decline (SCD).
Giulia Giacomucci, Assunta Ingannato, Chiara Crucitti, Silvia Bagnoli, Elisa Marcantelli, Sonia Padiglioni, Valentina Moschini, Carmen Morinelli, Laura Falsini, Sandro Sorbi, Valentina Berti, Benedetta Nacmias, Valentina Bessi   +12 more
wiley   +1 more source

Impact of middle leaders' competencies on teachers' technology acceptance in Malaysian TS25 schools. [PDF]

PLoS One
Yip J, Cheah KSL, Beh WF.
europepmc   +1 more source

A PRACTICAL USING OF THE QUEST PROGRAM TO ANALYZE THE CHARACTERISTICS OF THE TEST ITEMS IN EDUCATIONAL MEASUREMENT

, 2023
Ikhsanudin Ikhsanudin, Novaliah Novaliah, Hidayatullah Hidayatullah, Memi Almizi   +3 more
openalex   +2 more sources